Section of Hematology / Oncology
Professor of Medicine
Associate Dean for Global Health;
Walter L. Palmer Distinguished Service Professor;
Director, Center for Clinical Cancer Genetics
Referring Physician Access Line: 1-877-DOM-2730
|MD||1980||University of Ibadan||
|Residency||1986||Cook County Hospital||Internal Medicine
|Residency||1986||Cook County Hospital||Chief Resident
|Fellowship||1991||The University of Chicago||Hematology/Oncology
A leader in cancer genetics, Dr. Olopade studies familial forms of cancers, molecular mechanisms of tumor progression in high-risk individuals as well as genetic and non-genetic factors contributing to tumor progression in diverse populations. Her current laboratory research is focused on using whole genome technologies and bioinformatics to develop innovative approaches to democratize precision health care for all and thereby reduce global health disparities.
Dr. Olopade is an expert in cancer risk assessment and individualized treatment for the most aggressive forms of breast cancer based on an understanding of the altered genes in individual patients. She stresses comprehensive risk reducing strategies and prevention in high-risk populations, as well as earlier detection through advanced imaging technologies.
Dr. Olopade is an at-large member of the American Board of Internal Medicine Board of Directors. She is also an elected member of the American Society for Clinical Investigation, the Association of American Physicians, the Institute of Medicine of the National Academies, the American Academy of Arts and Sciences and the American Philosophical Society. She has received numerous honors and awards, including honorary degrees from Bowdoin University, Princeton University, North Central College and Dominican University, Doris Duke Distinguished Clinical Scientist and Exceptional Mentor Award, American Cancer Society Clinical Research Professorship, MacArthur Foundation Fellowship, Officer of the Order of the Nigeria Award, and the Franklin D. Roosevelt Freedom from Want Award. Dr. Olopade currently serves on the Board of Directors for the National Cancer Advisory Board, Susan G. Komen for the Cure and the Lyric Opera.
Breast cancer, cancer risk assessment, cancer prevention and general hematology and medical oncology.
- Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL; Prevention and Observation of Surgical End Points Study Group. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
N Engl J Med. 2002 May 23;346(21):1616-22. Epub 2002 May 20.
- Huo Z, Giger ML, Olopade OI, Wolverton DE, Weber BL, Metz CE, Zhong W, Cummings SA.Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers. Radiology. 2002 Nov;225(2):519-26.
- Adebamowo CA, Ogundiran TO, Adenipekun AA, Oyesegun RA, Campbell OB, Akang EE, Rotimi CN, Olopade OI. Waist-hip ratio and breast cancer risk in urbanized Nigerian women. Breast Cancer Res. 2003;5(2):R18-24. Epub 2002 Dec 19.
- Grushko TA, Blackwood MA, Schumm PL, Hagos FG, Adeyanju MO, Feldman MD, Sanders MO, Weber BL, Olopade OI. Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers. Cancer Res. 2002 Mar 1;62(5):1481-8.
- Olopade OI, Pomykala HM, Hagos F, Sveen LW, Espinosa R 3rd, Dreyling MH, Gursky S, Stadler WM, Le Beau MM, Bohlander SK. Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6489-93.